Altimmune (ALT) Surges Another 16% After Yesterday’s Solid Rally

The Altimmune Inc (NASDAQ: ALT) stock in focus among investors during the premarket trading period this morning and this far, the stock has rallied by as high as 16%.

ALT had been in action on Thursday as well when it ended the day with gains of 15%. This morning it emerged that Altimmune is all set to further expand its manufacturing agreement related to the product AdCOVID with Lonza. AdCOVID is the company’s one dose COVID 19 vaccine and Lonza had been contracted to take care of the manufacturing process.

As per the expansion agreement between the two parties, Lonza is going to set aside a manufacturing suite specifically meant for AdCOVID at its facility located in Houston. The suite in question is going to be used for both clinical uses and also for the commercial production of the product. The announcement seems to have come as a source of excitement for many investors and that can be seen from the price action in the Altimmune stock.

Anthony Gonzales

Biotech, Tech, and Crypto reporter Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.

Want Hot Stocks?    Yes. I Love Them No thanks